Perspective Therapeutics, Inc.
General ticker "CATX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $222.4M (TTM average)
Perspective Therapeutics, Inc. follows the US Stock Market performance with the rate: 22.7%.
Estimated limits based on current volatility of 20.2%: low 3.61$, high 5.00$
Factors to consider:
- Total employees count: 140 as of 2024
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.52$, 7.72$]
- 2025-12-31 to 2026-12-31 estimated range: [2.46$, 6.89$]
Short-term CATX quotes
Long-term CATX plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $10.46MM |
| Operating Income | $10.46MM |
| Non-Operating Income | $-91.83MM |
| Interest Expense | $0.05MM |
| R&D Expense | $41.64MM |
| Income(Loss) | $-81.38MM |
| Taxes | $-2.10MM |
| Profit(Loss)* | $-79.28MM |
| Stockholders Equity | $290.67MM |
| Assets | $341.10MM |
| Operating Cash Flow | $-18.29MM |
| Capital expenditure | $54.41MM |
| Investing Cash Flow | $-218.93MM |
| Financing Cash Flow | $289.38MM |
| Earnings Per Share** | $-1.23 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.